Revolution Medicines, Inc. (RVMD)
206.64
+0.75
(+0.36%)
USD |
NASDAQ |
Oct 02, 16:00
206.50
-0.14
(-0.07%)
After-Hours: 20:00
Revolution Medicines Market Cap : 44.27B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 44.27B |
| October 01, 2026 | 44.11B |
| September 30, 2026 | 43.98B |
| September 29, 2026 | 43.81B |
| September 28, 2026 | 43.22B |
| September 25, 2026 | 43.91B |
| September 24, 2026 | 42.82B |
| September 23, 2026 | 40.86B |
| September 22, 2026 | 41.32B |
| September 21, 2026 | 41.30B |
| September 18, 2026 | 40.91B |
| September 17, 2026 | 42.19B |
| September 16, 2026 | 41.97B |
| September 15, 2026 | 43.89B |
| September 14, 2026 | 43.94B |
| September 11, 2026 | 43.66B |
| September 10, 2026 | 43.57B |
| September 09, 2026 | 44.49B |
| September 08, 2026 | 44.42B |
| September 04, 2026 | 45.00B |
| September 03, 2026 | 45.18B |
| September 02, 2026 | 44.83B |
| September 01, 2026 | 44.96B |
| August 31, 2026 | 44.04B |
| August 28, 2026 | 44.54B |
| Date | Value |
|---|---|
| August 27, 2026 | 47.38B |
| August 26, 2026 | 46.16B |
| August 25, 2026 | 45.29B |
| August 24, 2026 | 45.33B |
| August 21, 2026 | 44.88B |
| August 20, 2026 | 45.36B |
| August 19, 2026 | 45.99B |
| August 18, 2026 | 46.28B |
| August 17, 2026 | 45.42B |
| August 14, 2026 | 43.64B |
| August 13, 2026 | 43.28B |
| August 12, 2026 | 43.98B |
| August 11, 2026 | 44.04B |
| August 10, 2026 | 44.34B |
| August 07, 2026 | 43.95B |
| August 06, 2026 | 42.38B |
| August 05, 2026 | 42.27B |
| August 04, 2026 | 41.45B |
| August 03, 2026 | 39.09B |
| July 31, 2026 | 37.54B |
| July 30, 2026 | 38.47B |
| July 29, 2026 | 36.22B |
| July 28, 2026 | 36.80B |
| July 27, 2026 | 37.65B |
| July 24, 2026 | 37.88B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 75.81B |
| Arrowhead Pharmaceuticals, Inc. | 9.059B |
| Intellia Therapeutics, Inc. | 1.717B |
| Beam Therapeutics, Inc. | 2.530B |
| Prime Medicine, Inc. | 538.60M |
Market Cap Related Metrics
| PEG Ratio | -0.245 |
| Price to Book Value | 16.99 |
| Price | 206.64 |
| Earnings Yield | -4.27% |
| PEGY Ratio | -0.245 |